| 发明名称 | Factor VII composition | ||
| 摘要 | The invention relates to a stable pharmaceutical composition in liquid form or in solid form, comprising factor VII, said composition being free of mannitol and of sucrose, or even also of any antioxidant. | ||
| 申请公布号 | US9029316(B2) | 申请公布日期 | 2015.05.12 |
| 申请号 | US201013377680 | 申请日期 | 2010.06.18 |
| 申请人 | Laboratoire Francais du Fractionnement Et des Biotechnologies | 发明人 | Bardat Annie;Pompe Cornelius |
| 分类号 | A61K38/48;A61P7/04 | 主分类号 | A61K38/48 |
| 代理机构 | Cesari and McKenna, LLP | 代理人 | Cesari and McKenna, LLP |
| 主权项 | 1. A pharmaceutical composition in liquid form or in solid form, comprising factor VII, arginine, isoleucine, lysine, glycine, and trisodium citrate or calcium chloride, wherein said composition is free of mannitol, glycylglycine, and sucrose; and the factor VII is in activated form and is obtained by genetic engineering from cells or from transgenic animals. | ||
| 地址 | Les Ulis FR | ||